Murphy & Mullick Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.7M Buy
1,416
+10
+0.7% +$10.2K 1.05% 21
2026
Q1
$1.29M Buy
1,406
+4
+0.3% +$4.05K 0.96% 26
2025
Q4
$1.51M Sell
1,402
-61
-4% -$58.3K 1.09% 20
2025
Q3
$1.13M Sell
1,463
-50
-3% -$37.2K 0.84% 26
2025
Q2
$1.12M Buy
1,513
+1
+0.1% +$777 0.91% 26
2025
Q1
$1.25M Sell
1,512
-125
-8% -$104K 1.21% 19
2024
Q4
$1.26M Buy
+1,637
New +$1.36M 1.16% 19

Other funds holding LLY

Murphy & Mullick Capital Management's LLY Position: Q2 2026 in Review

Murphy & Mullick Capital Management increased its Eli Lilly (LLY) stake by 0.71% in Q2 2026, buying an estimated $10.2K and bringing the position to 1,416 shares worth $1.7M. The position accounts for 1.05% of the portfolio, ranked #21.

Murphy & Mullick Capital Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Murphy & Mullick Capital Management held 1,416 shares of Eli Lilly worth $1.7M as of Q2 2026.
  • Murphy & Mullick Capital Management bought 10 Eli Lilly shares in Q2 2026, an estimated $10.2K.
  • Eli Lilly made up 1.05% of Murphy & Mullick Capital Management's portfolio in Q2 2026, its #21 holding.
  • Murphy & Mullick Capital Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.